MOH — authorised 20 November 2008
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Status: likely_approved
MOH authorised Promacta on 20 November 2008
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 20 November 2008.
NOVARTIS PHARMS CORP holds the UAE marketing authorisation.